Skip to Content

LFTD Partners Inc LIFD

Morningstar Rating
$0.87 +0.27 (44.35%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LIFD is trading at a 81% premium.
Price
$0.87
Fair Value
$2.71
Uncertainty
Extreme
1-Star Price
$5.85
5-Star Price
$6.91
Economic Moat
Hmm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LIFD is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.60
Day Range
$0.870.87
52-Week Range
$0.483.05
Bid/Ask
$0.55 / $0.92
Market Cap
$12.84 Mil
Volume/Avg
251 / 4,664

Key Statistics

Price/Earnings (Normalized)
22.67
Price/Sales
0.29
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

LFTD Partners Inc along with its subsidiaries manufactures and sells hemp-derived and other psychoactive products under the Urb Finest Flowers brand. Its products include disposable vapes and cartridges, gummies, joints, blunts, and products containing ingredients such as kanna, muscimol, ashwagandha, and kava.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
166

Valuation

Metric
LIFD
Price/Earnings (Normalized)
22.67
Price/Book Value
0.34
Price/Sales
0.29
Price/Cash Flow
3.05
Price/Earnings
LIFD

Financial Strength

Metric
LIFD
Quick Ratio
1.34
Current Ratio
2.62
Interest Coverage
8.04
Quick Ratio
LIFD

Profitability

Metric
LIFD
Return on Assets (Normalized)
9.29%
Return on Equity (Normalized)
11.59%
Return on Invested Capital (Normalized)
10.89%
Return on Assets
LIFD
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
NfmsdsfgwfFcv$81.5 Bil
Merck KGaA ADR
MKKGY
YtnjynhlwVbxmmt$70.9 Bil
Haleon PLC ADR
HLN
YqzzczlmwRdq$40.1 Bil
Viatris Inc
VTRS
QzcjcjvjBmtfl$14.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
ZdhhbmvxHmdrf$13.2 Bil
Catalent Inc
CTLT
JdzngyxtNhmzyfw$10.5 Bil
Perrigo Co PLC
PRGO
RywmcwkdWlwkc$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
HyvznsvbMtvdth$3.5 Bil
Curaleaf Holdings Inc
CURLF
DklbddftlRfrw$3.1 Bil
Green Thumb Industries Inc
GTBIF
JfxpzhskxFnwt$2.6 Bil

Sponsor Center